Clinical Outcomes of a 14-Day In-Hospital Stay Program in Patients Undergoing Head and Neck Cancer Surgery With Free Flap Reconstruction Under the National Health Insurance System
- Author:
Ji Eun CHOI
1
;
Heejung KIM
;
Sung Yong CHOI
;
Jongwon PARK
;
Man Ki CHUNG
;
Chung Hwan BAEK
;
Han Sin JEONG
Author Information
- Publication Type:Original Article
- Keywords: Head and Neck Neoplasms; Reconstructive Surgical Procedures; Length of Stay; Outcomes
- MeSH: Biomarkers; Early Ambulation; Free Tissue Flaps; Head and Neck Neoplasms; Head; Humans; Incidence; Length of Stay; National Health Programs; Postoperative Care; Postoperative Complications; Reconstructive Surgical Procedures; Risk Factors; Salvage Therapy; Wounds and Injuries
- From:Clinical and Experimental Otorhinolaryngology 2019;12(3):308-316
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVES: Length of in-hospital stay (LOS) is often regarded as a surrogate marker of efficiency in medical care. A shorter stay can redistribute medical resources to more patients if patient outcomes would not be worsened. However, the adequate LOS remains largely understudied for a complex head and neck cancer (HNC) surgery and free flap reconstruction. METHODS: Active management of LOS (14-day LOS program) included detailed preoperative surgical planning, intensive wound care, postoperative early ambulation and positive psychological encouragement. It was applied to 43 patients undergoing HNC surgery and free flap reconstruction. Outcomes such as noninferior oncological results, rates of timely adjuvant treatments and complications were compared with those of 125 patients without active management of LOS. In addition, the medical costs of shortened LOS were compared with those of the control group. Cases undergoing HNC surgery as a salvage treatment were excluded from both groups for analyses. RESULTS: Active management of LOS resulted in less in-hospital period compared to the control group (15.0 vs. 21.0 days, P=0.001), and reduced medical costs significantly. Incidence of postoperative complications was comparable between the two groups. Oncological outcomes did not differ significantly according to LOS. In all patients in both groups, initial high T status (T3–4) and occurrence of postoperative complications were independent risk factors for long LOS (>30 days). CONCLUSION: In patients undergoing HNC surgery with free flap reconstruction as an initial treatment, a 14-day LOS could be safe in terms of comparable oncological outcomes and postoperative complications. To achieve this goal safely, careful management for T3–4 tumors and prevention of postoperative complications seem to be necessary.
